Pas­sage of FDA Mod­ern­iza­tion Act 2.0 clears the way to re­duce an­i­mal test­ing

While the fu­ture of drug de­vel­op­ment like­ly won’t be com­plete­ly an­i­mal-free, thanks to the pas­sage of the FDA Mod­ern­iza­tion Act 2.0, there may be less use of an­i­mals in sit­u­a­tions where they aren’t nec­es­sary.

The bill, which was added to the 2023 spend­ing pack­age that Pres­i­dent Joe Biden signed in­to law last week, doesn’t ban an­i­mal test­ing out­right, but it al­lows drug de­vel­op­ers to use al­ter­na­tive meth­ods to in­ves­ti­gate the safe­ty and ef­fec­tive­ness of a new drug.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.